ERBB2 and breast cancer: In a pooled analysis of 11,955 patients having NAC from 1990 to 2011, the strongest association between pCR and RFS was in patients with aggressive breast cancer subtypes (triple-negative, ER + (grade 3) HER2-, ER-HER2 +) [22].